Ovarian cancer is the most lethal gynaecological malignancy, but its incidence in the general population is low. Due to the lack of effective prevention and successful screening approaches, most cases are diagnosed at advanced stages, leading to poor prognosis. In order to address the research requirements pertaining to ovarian cancer, the Shanghai Ovarian Cancer and Family Care Project was established. This initiative offers hospital-based resources for investigating ovarian cancer and high-risk populations. The project comprises an on-going ovarian cancer cohort, a high-risk population cohort, and a healthy population cohort. By leveraging these comprehensive cohorts, the project provides a unique platform for in-depth studies on the detection, prevention, early diagnosis, treatment, and prognosis of ovarian cancer.
Study Type
OBSERVATIONAL
Enrollment
3,546
Shanghai first maternity and infant hospital
Shanghai, Shanghai Municipality, China
RECRUITINGDeath due to ovarian cancer
Death due to ovarian cancer determined by independent outcomes committee.
Time frame: From diagnosis of ovarian cancer until October 31, 2028.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.